Strengths

1 - Strong property infrastructure (Digitization & automation in all process )

2 - Strategic alliances to accelerate advancement of potential mRNA drugs

3 – Patent and IP estate as strategic assets

4 – Covid 19 vaccine from Moderna’s stable helping fight global health emergency

5- Having high qualified staff.

6- Have good support and strong relationship with Government and associations (he Defense Advanced
research projects agency DARPA $ Gates foundation .

Weaknesses

1 – Poor track record with no marketable products and no revenue

2 – Continuous losses since inception as Moderna never brought product to market

3 – lack of experience in sales and distribution

Opportunities

1 – Massachusetts as a booming biotech hub

2 – mRNA potential for new class of medicines

3 – Untapped local production

4- The reduced cycle times allowed Moderna to move in a faster pace than other biotech companies

Threats

1 – Covid 19 Vaccine efficiency and results side effect may attract fresh trouble for the pharma giant

2 – Dependence on progression of modalities

3 – Regulatory changes may increase the competition from biosimilars

4 – Risks inherent in pharmaceutical operations and supply chain

IFE : IFE matrix the above-obtained sum of weighted values is equal to 3.30 that shows Moderna in a
good position as the value is above 2.50
EFE: Based on the EFE matrix the above obtained sum of values is weighted by 2.90 shows that Moderna
was in a strong position Because it has a number of weighted values more than 2.5 the means Moderna
can take advantage of the owned opportunities and overcome such threats